Merck May Consider Settling Some Vioxx Suits
This article was originally published in The Pink Sheet Daily
Executive Summary
Representing a shift in legal strategy, Merck may re-evaluate cases involving patients who took Vioxx for long periods of time and had few risk factors for heart disease.